Filing Details
- Accession Number:
- 0001209191-16-119856
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-13 15:20:53
- Reporting Period:
- 2016-05-11
- Filing Date:
- 2016-05-13
- Accepted Time:
- 2016-05-13 15:20:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-11 | 5,130 | $35.35 | 270,414 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-05-11 | 430 | $83.90 | 269,984 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-11 | 1,200 | $85.26 | 268,784 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-11 | 1,600 | $86.78 | 267,184 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-11 | 1,400 | $87.43 | 265,784 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-11 | 500 | $88.20 | 265,284 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-05-11 | 5,130 | $0.00 | 5,130 | $35.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
41,050 | 2016-07-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13,286 | Indirect | 401(k) |
Common Stock | 122,700 | Indirect | Common Stock Held In Trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $83.90 (range $83.60 to $84.42).
- Open market sales reported on this line occurred at a weighted average price of $85.26 (range $84.76 to $85.73).
- Open market sales reported on this line occurred at a weighted average price of $86.78 (range $86.11 to $87.10).
- Open market sales reported on this line occurred at a weighted average price of $87.43 (range $87.13 to $88.10).
- Open market sales reported on this line occurred at a weighted average price of $88.20 (range $88.14 to $88.26).
- Fully vested.